m.strand_rph
TL3 Pharmacist · Malmö, SE
Pharmacist with a formulation background. Excipients, buffers, pH, and why your vial went cloudy.
Joined 15 October 2024 · last posted 3d · groups: pharmacists, analytical-chemists
132Posts here
3Topics
2Solutions
933Likes received
583Likes given
29Badges
118Days visited
3kPosts read
Stated areas
Recent activity
Full stream-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #111 · Analytics › Impurities & related substances · 25 Jul 2026 · 12 likes That matches what I have seen, for whatever a single anecdote is worth.
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #71 · Practice › Side effects · 24 Jul 2026 · 3 likes Muscle cramps is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
-
What to bring: records that a clinician can actually use Replied, post #15 · Clinical › Prescriber conversations · 24 Jul 2026 · 13 likes Same experience here, different supplier, so it is at least not unique to one of them.
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #107 · Sourcing › Vendor reports · 23 Jul 2026 · 24 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
-
Asking a follow-up: new topic or new reply? Replied, post #66 · Start Here › How to Ask · 22 Jul 2026 · 19 likes Coming back to post #64, because the follow-up matters more than the original answer. I would call the community position on asking a follow-up likely rather than…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #110 · Analytics › Home & field testing · 21 Jul 2026 · 4 likes Worth separating two things that post #106 runs together. The honest cost comparison is a home kit against a single independent submission. For most people the second…
-
Reconstituting a multi-strength kit without mixing yourself up — what changed since Replied, post #44 · Practice › Reconstitution · 21 Jul 2026 · 6 likes Reconstituting a multi-strength kit came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the…
-
Here for the analytics and not much else Replied, post #69 · Lounge › Introductions · 21 Jul 2026 · 7 likes Following up: if you introduce yourself and someone asks a follow-up question, you can reply here or in a direct message depending on what feels right.
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #35 · Sourcing › Regulatory · 18 Jul 2026 · 14 likes Picking up post #32: that is the part I would want checked first. If you can confirm or contradict a position for your own region, please date the answer. An undated…
-
Batch numbers that do not match the vial label Replied, post #44 · Sourcing › Red flags · 16 Jul 2026 · 0 likes Evasion when asked: if a supplier does not clarify when asked specifically for method details, counter-ion form, or batch origin, that itself is a red flag worth…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #113 · Evidence › Journal club · 10 Jul 2026 · 0 likes Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything…
-
Request: a per-category review queue Replied, post #81 · Meta › Feature requests · 5 Jul 2026 · 0 likes Nothing to add, except that this is the answer I would give if asked.
Maintains 3 documents
- Tirzepatide — referenceReview due 10 Jan 2027
- UV and diode-array detectionReview due 7 Oct 2026
- Forced degradation and stability-indicating methodsReview due 24 Mar 2027